In contrast, for the PD-L1 expression and PD-1 checkpoint pathway in cancer and choline metabolism in cancer KEGG pathways, BED-related LPFS differences were observed only in wild-type tumors (p = 0.009 and 0.01, respectively), with no such differences in mutation-positive groups (Figure 3). Here, CD274 is linked to cancer.